Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial

Cerebrovascular Diseases

Volumn 29, Issue 1, 2009, Pages 14-21

  De Silva, D A ^a,b   Ebinger, M ^a,c   Christensen, S ^a,d   Parsons, M W ^e   Levi, C ^e   Butcher, K ^f   Barber, P A ^g   Bladin, C ^h   Donnan, G A ^d,i   Davis, S M ^a,d  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^c Center for Stroke Research Berlin   (Germany)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f UNIVERSITY OF ALBERTA   (Canada)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

^h MONASH UNIVERSITY   (Australia)

ⁱ FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Diabetes; Glucose; Hyperglycemia; Infarct growth; Ischemic stroke

Indexed keywords

GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN INFARCTION SIZE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ECHO PLANAR IMAGING; FEMALE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STROKE; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; AUSTRALIA; BLOOD GLUCOSE; DIABETES MELLITUS; DRUG ADMINISTRATION SCHEDULE; EUROPE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYPERGLYCEMIA; INFUSIONS, INTRAVENOUS; LINEAR MODELS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; NEW ZEALAND; PATIENT ADMISSION; PATIENT SELECTION; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; RISK ASSESSMENT; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 70350653552     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000255969     Document Type: Article

References (59)

1. Tissue plasminogen activator for acute ischemic stroke: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-1587.
2. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G: Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369: 275-282.
3. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
4. Baird TA, Parsons MW, Barber PA, Butcher KS, Desmond PM, Tress BM, Colman PG, Jerums G, Chambers BR, Davis SM: The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome. J Clin Neurosci 2002; 9: 618-626.
5. Kiers L, Davis SM, Larkins R, Hopper J, Tress B, Rossiter SC, Carlin J, Ratnaike S: Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry 1992; 55: 263-270.
6. Lees KR, Walters MR: Acute stroke and diabetes. Cerebrovasc Dis 2005; 20: 9-14.
7. Fuentes B, Diez-Tejedor E: General care in stroke: relevance of glycemia and blood pressure levels. Cerebrovasc Dis 2007; 24: 134-142.
8. Diez-Tejedor E, Fuentes B: Acute care in stroke: the importance of early intervention to achieve better brain protection. Cerebrovasc Dis 2004; 17: 130-137.
9. Quinn TJ, Lees KR: Hyperglycemia in acute stroke-to treat or not to treat. Cerebrovas Dis 2009; 27: 148-155.
10. Allport L, Baird T, Butcher K, Macgregor L, Prosser J, Colman P, Davis S: Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care 2006; 29: 1839-1844.
11. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 2426-2432.
12. Weir CJ, Murray GD, Dyker AG, Lees KR: Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 1997; 314: 1303-1306.
13. Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F: Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 1983; 74: 540-544.
14. Oppenheimer SM, Hoffbrand BI, Oswald GA, Yudkin JS: Diabetes mellitus and early mortality from stroke. Br Med J (Clin Res Ed) 1985; 291: 1014-1015.
15. Asplund K, Hagg E, Helmers C, Lithner F, Strand T, Wester PO: The natural history of stroke in diabetic patients. Acta Med Scand 1980; 207: 417-424.
16. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM: Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002; 52: 20-28.
17. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997; 28: 2119-2125.
18. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE: Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial. Neurology 2002; 59: 669-674.
19. Arenillas JF, Ispierto L, Millan M, Escudero D, Perez De La Ossa N, Dorado L, Guerrero C, Serena J, Castillo J, Davalos A: Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke. Neurology 2008; 71: 190-195.
20. Ribo M, Molina C, Montaner J, Rubiera M, Delgado-Mederos R, Arenillas JF, Quintana M, Alvarez-Sabin J: Acute hyperglycemia state is associated with lower tPA-induced recanalisation rates in stroke patients. Stroke 2005; 36: 1705-1709.
21. Els T, Klisch J, Orszagh M, Hetzel A, Schulte-Monting J, Schumacher M, Lucking CH: Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc Dis 2002; 13: 89-94.
22. Ribo M, Molina CA, Delgado P, Rubiera M, Delgado-Mederos R, Rovira A, Munuera J, Alvarez-Sabin J: Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA. J Cereb Blood Flow Metab 2007; 27: 1616-1622.
23. Alvarez-Sabin J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribo M, Codina A, Quintana M: Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 2003; 34: 1235-1241.
24. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM: Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7: 299-309.
25. Davis SM, Donnan GA, Butcher KS, Parsons M: Selection of thrombolytic therapy beyondh using magnetic resonance imaging. Curr Opin Neurol 2005; 18: 47-52.
26. Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C, Levi C, Kimber T, Schultz D, Fink J, Tress B, Donnan G, Davis S: Refining the perfusion-diffusion mismatch hypothesis. Stroke 2005; 36: 1153-1159.
27. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S: The Desmoteplase in Acute Ischemic Stroke trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36: 66-73.
28. Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA, Davis SM: Diffusion-and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002; 51: 28-37.
29. Barber PA, Parsons MW, Desmond PM, Bennett DA, Donnan GA, Tress BM, Davis SM: The use of PWI and DWI measures in the design of 'proof-of-concept' stroke trials. J Neuroimaging 2004; 14: 123-132.
30. Arenillas JF, Rovira A, Molina CA, Grive E, Montaner J, Alvarez-Sabin J: Prediction of early neurological deterioration using diffusion-and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke. Stroke 2002; 33: 2197-2203.
31. Rother J, Schellinger PD, Gass A, Siebler M, Villringer A, Fiebach JB, Fiehler J, Jansen O, Kucinski T, Schoder V, Szabo K, Junge-Hulsing GJ, Hennerici M, Zeumer H, Sartor K, Weiller C, Hacke W: Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke ! 6 hours. Stroke 2002; 33: 2438-2445.
32. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, Ergin A: Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999; 99: 2239-2242.
33. Islam MM, Ali A, Khan NA, Rahman A, Majumder AS, Chowdhury WA, Faruque GM, Faruque M, Jalaluddin M: Comparative study of coronary collaterals in diabetic and nondiabetic patients by angiography. Mymensingh Med J 2006; 15: 170-175.
34. De Vivo S, Palmer-Kazen U, Kalin B, Wahlberg E: Risk factors for poor collateral development in claudication. Vasc Endovascular Surg 2005; 39: 519-524.
35. Sacco RL, Foulkes MA, Mohr JP, Wolf PA, Hier DB, Price TR: Determinants of early recurrence of cerebral infarction. The Stroke Data Bank. Stroke 1989; 20: 983-989.
36. Cambon H, Derouesne C, Yelnik A, Duyckaerts C, Hauw JJ: Effect of diabetes mellitus and blood glucose on the size of cerebral infarction and causes of death: neuropathological study of 77 cases of infarction in the sylvian artery area (in French). Rev Neurol (Paris) 1991; 147: 727-734.
37. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, Kaste M, Lipka LJ, Pedraza S, Ringleb PA, Rowley HA, Schneider D, Schwamm LH, Leal JS, Sohngen M, Teal PA, Wilhelm-Ogunbiyi K, Wintermark M, Warach S: Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009; 8: 141-150.
38. Pulsinelli WA, Waldman S, Rawlinson D, Plum F: Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology 1982; 32: 1239-1246.
39. Lin B, Ginsberg MD, Busto R: Hyperglycemic exacerbation of neuronal damage following forebrain ischemia: microglial, astrocytic and endothelial alterations. Acta Neuropathol 1998; 96: 610-620.
40. Lindsberg PJ, Roine RO: Hyperglycemia in acute stroke. Stroke 2004; 35: 363-364.
41. Anderson RE, Tan WK, Martin HS, Meyer FB: Effects of glucose and PaO 2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 1999; 30: 160-170.
42. Li PA, Shuaib A, Miyashita H, He QP, Siesjo BK, Warner DS: Hyperglycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia. Stroke 2000; 31: 183-192.
43. Wei J, Huang NC, Quast MJ: Hydroxyl radical formation in hyperglycemic rats during middle cerebral artery occlusion/reperfusion. Free Radic Biol Med 1997; 23: 986-995.
44. Berger L, Hakim AM: The association of hyperglycemia with cerebral edema in stroke. Stroke 1986; 17: 865-871.
45. Kawai N, Keep RF, Betz AL: Effects of hyperglycemia on cerebral blood flow and edema formation after carotid artery occlusion in Fischer 344 rats. Acta Neurochir 1997; 70(suppl):34-36.
46. Lindsberg PJ, Kaste M: Thrombolysis for acute stroke. Curr Opin Neurol 2003; 16: 73-80.
47. De Courten-Myers GM, Kleinholz M, Holm P, DeVoe G, Schmitt G, Wagner KR, Myers RE: Hemorrhagic infarct conversion in experimental stroke. Ann Emerg Med 1992; 21: 120-126.
48. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26: 57-65.
49. Van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367.
50. Kreisel SH, Berschin UM, Hammes HP, Leweling H, Bertsch T, Hennerici MG, Schwarz S: Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment. Cerebrovasc Dis 2008; 27: 167-175.
51. Walters MR, Weir CJ, Lees KR: A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis 2006; 22: 116-122.
52. Kreisel SH, Berschin UM, Hammes HP, Leweling H, Bertsch T, Hennerici MG, Schwarz S: Pragmatic management of hyperglycemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment. Cerebrovasc Dis 2009; 27: 167-175.
53. Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NE, Bamford JM, James OF, Alberti KG: Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in stroke trial (GIST-UK). Lancet Neurol 2007; 6: 397-406.
54. Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, Kissela BM, Williams LS: Treatment of Hyperglycemia in Ischemic Stroke (THIS): a randomized pilot trial. Stroke 2008; 39: 384-389.
55. The Glucose Regulation in Acute Stroke Patients (GRASP) trial. www.strokecenter.org/trials/trialdetail.aspx?tid=681 (accessed April 18th 2008).
56. Molina CA, Montaner J, Abilleira S, Arenillas JF, Ribo M, Huertas R, Romero F, Alvarez-Sabin J: Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case-control study. Stroke 2001; 32: 2821-2827.
57. De Silva DA, Fink JN, Christensen S, Ebinger M, Bladin C, Levi CR, Parsons M, Butcher K, Barber PA, Donnan GA, Davis SM, the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators: assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke 2009, E-pub ahead of print.
58. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM: Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003; 34: 2208-2214.
59. Allport LE, Butcher KS, Baird TA, Mac-Gregor L, Desmond PM, Tress BM, Colman P, Davis SM: Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke 2004; 35: 1886-1891.